United Pharmacy Network (UPN) and Applied DNA Sciences Enter Into Agreement to Promote SmokeCloak ® DNA Systems
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter:@APDN),a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions,enters into an agreement with United Pharmacy Network to recommend the award winning Smoke Cloak® DNA system to its 160 members in the NY metro area and several other states, primarily Texas.
When deployed in pharmacies, banks, commercial/retail locations, Smoke Cloak DNA helps protect staff, customers and assets. A thick and disorienting fog wards off offenders and deposits a unique, location-specific DNA marker on skin, clothing and stolen items.
UPN CEO Sam Maddali commented, “We are thrilled to offer this very innovative and safe security technology to our members.The combination of fog and DNA technologies strikes fear into criminal hearts; deterrence levels soar.”
Each year, Popular Science reviews thousands of new products and chooses the top 100 winners across 12 categories for inclusion. Smoke Cloak DNA was chosen for its significant innovation and effectiveness in protecting commerce and safety.
“We are excited to be entering into this agreement with UPN, being able to supply a security solution that is as effective as Smoke Cloak DNA, benefits both the pharmacy and its customers,”said Dr.James A Hayward, President and CEO of Applied DNA Sciences. “We believe that we will be able to recruit other member groups for jewelry stores, pawn shops and other industry verticals.”
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands,entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digital DNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward-Looking Statement The statements made by APDN in this press release may be “forward-looking”in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 15,2014, and our subsequent quarterly report on Form 10-Q which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.